John Paul II Hospital-ko ikertzaileekin lankidetzan egindako argitalpenak (1)

2021

  1. Oral vinorelbine and cisplatin as first-line therapy for advanced squamous NSCLC patients: a prospective randomized international phase II study (NAVoTrial 03)

    Therapeutic Advances in Medical Oncology, Vol. 13